SN

Sreenivasulu Naguboyina

Active Director Managing Director DIN 09370387
DIN 09370387 First appointment Oct 2021 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sreenivasulu Naguboyina

Data last updated:

Sreenivasulu Naguboyina is a Managing Director at Avamed Pharma Private Limited (since 2021). The company operates in Trading.

DIN 09370387
Primary Designation Managing Director
Industry Trading
First Appointment 22 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avamed Pharma Private Limited U51909AP2021PTC119808
Managing Director22 Oct 20212021Active

Board colleagues of Sreenivasulu Naguboyina

NameDINCompanyDesignation
Sai Mahesh Kaku08215429Avamed Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avamed Pharma Private Limited
Premium access

Shareholding and investment profile for Sreenivasulu Naguboyina

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreenivasulu Naguboyina

Sreenivasulu Naguboyina currently holds 1 directorship: Avamed Pharma Private Limited (Managing Director, since 22 Oct 2021).

Sreenivasulu Naguboyina was first appointed on 22 Oct 2021 as Managing Director at Avamed Pharma Private Limited.

The current boards of Sreenivasulu Naguboyina's companies include Sai Mahesh Kaku (Avamed Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available